Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp
Bullboard Posts
User Avatar Image
(168)
•••
Post by jwalliscaon Nov 21, 2019 12:26am
125 Views
Post# 30376840

Sernova in American Research for sale to High End

Sernova in American Research for sale to High EndProgressive Report on Live Cell Encapsulation Market Predictable to Witness Sustainable Industry Evolution Over 2028 - Sound On Sound Fest
n.b. The detailed report via one of the links within the link below will cost  U$3,995. 
 
 
Sernova is mentioned last on the list with Viacyte much earlier. Sernova is light years ahead of Viacyte. Being an American Research effort, it is good to see Sernova finally getting recognized. 
 
The Terminator said it best: "Hasta La Vista Baby".
 
Cheers,  
jwall  
 
EXCERPT:
...Global Analysis and Forecasts by Growth focusing Manufacturers are (Evonik Industries AG, Balchem Corporation, BioTime Inc, Viacyte Inc, Neurotech Pharmaceuticals Inc, Living Cell Technologies Ltd, Merck KGAA, Sigilon Therapeutics Inc, Blacktrace Holdings Ltd, SERNOVA CORP.)
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities